Literature DB >> 24405622

Aquacel surgical dressing reduces the rate of acute PJI following total joint arthroplasty: a case-control study.

Jenny Cai1, Joseph A Karam1, Javad Parvizi1, Eric B Smith1, Peter F Sharkey1.   

Abstract

An effort to prevent PJI has led to the development of antimicrobial dressings that support wound healing. We sought to determine whether Aquacel Surgical dressing independently reduces the rate of acute PJI following TJA. A single institution retrospective chart review of 903 consecutive cases who received the Aquacel Surgical dressing and 875 consecutive cases who received standard gauze dressing was conducted to determine the incidence of acute PJI (within 3 months). The incidence of acute PJI is 0.44% in the Aquacel dressing group compared to 1.7% in the standard gauze dressing group (P = 0.005). Multivariate analysis revealed that use of Aquacel dressing was an independent risk factor for reduction of PJI (odds ratio of 0.165, 95% confidence interval: 0.051-0.533). Aquacel Surgical dressing significantly reduces the incidence of acute PJI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hip arthroplasty; knee arthroplasty; periprosthetic joint infection; wound dressing

Mesh:

Substances:

Year:  2013        PMID: 24405622     DOI: 10.1016/j.arth.2013.11.012

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  19 in total

1.  Randomized controlled trial of conventional versus modern surgical dressings following primary total hip and knee replacement.

Authors:  Jean Langlois; Amine Zaoui; Camille Ozil; Jean-Pierre Courpied; Philippe Anract; Moussa Hamadouche
Journal:  Int Orthop       Date:  2015-03-19       Impact factor: 3.075

2.  Are high-risk patient and revision arthroplasty effective indications for closed-incisional negative-pressure wound therapy after total hip or knee arthroplasty? A systematic review and meta-analysis.

Authors:  Jun-Ho Kim; Dae-Hee Lee
Journal:  Int Wound J       Date:  2020-05-13       Impact factor: 3.315

3.  Comparison of silver-embedded occlusive dressings and negative pressure wound therapy following total joint arthroplasty in high BMI patients: a randomized controlled trial.

Authors:  Katherine A Lygrisse; Greg Teo; Vivek Singh; Nishanth Muthusamy; Ran Schwarzkopf; Long William
Journal:  Arch Orthop Trauma Surg       Date:  2022-07-02       Impact factor: 2.928

4.  A New Dressing System Reduces the Number of Dressing Changes in the Primary Total Knee Arthroplasty: A Randomized Controlled Trial.

Authors:  Shilong Su; Juan He; Chenggong Wang; Fawei Gao; Da Zhong; Pengfei Lei
Journal:  Front Surg       Date:  2022-05-03

Review 5.  Wound dressings for primary and revision total joint arthroplasty.

Authors:  Madhav Chowdhry; Antonia F Chen
Journal:  Ann Transl Med       Date:  2015-10

Review 6.  Intraoperative Considerations for Treatment/Prevention of Prosthetic Joint Infection.

Authors:  Linda I Suleiman; Daniel R Mesko; Denis Nam
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 7.  Contemporary Strategies to Prevent Infection in Hip and Knee Arthroplasty.

Authors:  Lachlan M Batty; Brent Lanting
Journal:  Curr Rev Musculoskelet Med       Date:  2020-08

8.  AQUACEL® Ag Surgical Dressing Reduces Surgical Site Infection and Improves Patient Satisfaction in Minimally Invasive Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.

Authors:  Feng-Chih Kuo; Bradley Chen; Mel S Lee; Shih-Hsiang Yen; Jun-Wen Wang
Journal:  Biomed Res Int       Date:  2017-08-02       Impact factor: 3.411

Review 9.  Total knee arthroplasty and infection: how surgeons can reduce the risks.

Authors:  Nicola Ratto; Chiara Arrigoni; Federica Rosso; Matteo Bruzzone; Federico Dettoni; Davide Edoardo Bonasia; Roberto Rossi
Journal:  EFORT Open Rev       Date:  2017-03-13

10.  Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial.

Authors:  S L Karlakki; A K Hamad; C Whittall; N M Graham; R D Banerjee; J H Kuiper
Journal:  Bone Joint Res       Date:  2016-08       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.